Crescita Therapeutics Inc.
CRRTF
$0.36
$0.01273.66%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.00M | 5.94M | 6.45M | 6.25M | 6.58M |
| Total Receivables | 1.66M | 1.09M | 1.19M | 941.60K | 1.68M |
| Inventory | 3.62M | 3.55M | 2.82M | 4.54M | 3.85M |
| Prepaid Expenses | -- | -- | 181.40K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 288.90K | 239.30K | -- | 329.40K | 331.70K |
| Total Current Assets | 11.57M | 10.82M | 10.64M | 12.05M | 12.45M |
|
|
|||||
| Total Current Assets | 11.57M | 10.82M | 10.64M | 12.05M | 12.45M |
| Net Property, Plant & Equipment | 1.69M | 1.59M | 1.68M | 1.68M | 1.21M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.05M | 1.10M | 1.21M | 1.39M | 1.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.52M | 1.42M | 1.39M | 1.40M | 1.37M |
| Total Assets | 16.05M | 15.14M | 15.13M | 16.79M | 16.77M |
|
|
|||||
| Total Accounts Payable | 4.07M | 4.21M | 3.47M | 4.10M | 3.33M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 351.20K | 329.80K | 326.00K | 335.30K | 327.30K |
| Total Finance Division Other Current Liabilities | 36.70K | 34.80K | 34.80K | 37.00K | 36.50K |
| Total Other Current Liabilities | 36.70K | 34.80K | 34.80K | 37.00K | 36.50K |
| Total Current Liabilities | 4.46M | 4.57M | 3.83M | 4.47M | 3.70M |
|
|
|||||
| Total Current Liabilities | 4.46M | 4.57M | 3.83M | 4.47M | 3.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.20K | 169.80K | 253.70K | 350.10K | 429.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 55.00K | 49.40K | 46.60K | 82.90K | 78.20K |
| Total Liabilities | 4.60M | 4.79M | 4.13M | 4.90M | 4.21M |
|
|
|||||
| Common Stock & APIC | 43.99M | 41.77M | 41.75M | 44.51M | 44.00M |
| Retained Earnings | -33.35M | -32.20M | -31.52M | -33.45M | -32.26M |
| Treasury Stock & Other | 805.10K | 770.20K | 770.80K | 829.00K | 819.80K |
| Total Common Equity | 11.45M | 10.34M | 11.00M | 11.89M | 12.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.45M | 10.34M | 11.00M | 11.89M | 12.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.45M | 10.34M | 11.00M | 11.89M | 12.56M |
|
|
|||||